Evidence map›Paper›PMID 33217990›Full record

ReviewMolecules (Basel, Switzerland)2020

Free Radicals as a Double-Edged Sword: The Cancer Preventive and Therapeutic Roles of Curcumin.

Nehal Gupta, Kshitij Verma, Sarath Nalla, Alok Kulshreshtha, Rajiv Lall, Sahdeo Prasad

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 154 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Recent patents on biotechnology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Hallmarks of Bacterial Vaginosis.Diagnostics (Basel, Switzerland) · 2025
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nehal GuptaDepartment of Medicine, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115, USA.ORCID 0000-0002-8931-5759
Kshitij VermaDiscovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.ORCID 0000-0001-9374-9050
Sarath NallaNoble Pharma, LLC, 4602 Domain Drive, Menomonie, WI 54751, USA.
Alok KulshreshthaNoble Pharma, LLC, 4602 Domain Drive, Menomonie, WI 54751, USA.
Rajiv LallNoble Pharma, LLC, 4602 Domain Drive, Menomonie, WI 54751, USA.
Sahdeo PrasadNoble Pharma, LLC, 4602 Domain Drive, Menomonie, WI 54751, USA.
Noble Life Sciences (United States) · USUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Free radicals, generally composed of reactive oxygen species (ROS) and reactive nitrogen species (RNS), are generated in the body by various endogenous and exogenous systems. The overproduction of free radicals is known to cause several chronic diseases including cancer. However, increased production of free radicals by chemotherapeutic drugs is also associated with apoptosis in cancer cells, indicating the dual nature of free radicals. Among various natural compounds, curcumin manifests as an antioxidant in normal cells that helps in the prevention of carcinogenesis. It also acts as a prooxidant in cancer cells and is associated with inducing apoptosis. Curcumin quenches free radicals, induces antioxidant enzymes (catalase, superoxide dismutase, glutathione peroxidase), and upregulates antioxidative protein markers-Nrf2 and HO-1 that lead to the suppression of cellular oxidative stress. In cancer cells, curcumin aggressively increases ROS that results in DNA damage and subsequently cancer cell death. It also sensitizes drug-resistant cancer cells and increases the anticancer effects of chemotherapeutic drugs. Thus, curcumin shows beneficial effects in prevention, treatment and chemosensitization of cancer cells. In this review, we will discuss the dual role of free radicals as well as the chemopreventive and chemotherapeutic effects of curcumin and its analogues against cancer.

Indexed as

AnimalsAntineoplastic AgentsAntioxidantsCurcuminFree RadicalsHumansNeoplasmsReactive Oxygen SpeciesAntineoplastic AgentsAntioxidantsCurcuminFree RadicalsReactive Oxygen Speciescancerchemopreventioncurcuminfree radicalsROStherapy

Identifiers

PMID33217990
PMCPMC7698794
OpenAlexW3100808943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.